Allergy care guides for primary care
Part of Immune system & allergy clinical trials.
This study tests easy-to-follow guides to help general doctors diagnose and treat allergies. It may help ensure you get the right care for your allergy symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of asthma, anaphylaxis, drug allergy, food allergy, rhinitis, or hives.
- You are at least 1 year old.
- You have health insurance coverage.
- You agree to take part in this research (for minors, a parent or guardian must agree).
- You are not already seeing an allergy specialist for your allergies.
- You have not taken part in a trial for allergy medication or immune system drugs in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
This study screens adults to better understand and manage asthma and allergic diseases. It may help identify treatments or management strategies that improve quality of life.
This trial tests a digital tool designed to help patients stick to their allergy immunotherapy schedule. If you have allergic rhinitis (with or without asthma) and are starting a new single-allergy treatment, you may be able to join.
This study tests whether a new AI tool can help primary care doctors better manage chronic conditions in their community practice. You might join if you're a doctor with at least 3 years of experience working at a local health center.
This study tests an AI-based tool that helps primary care doctors better understand and address the health concerns of older adults during appointments. Participating may improve the care you receive for new or worsening health issues.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.